Literature DB >> 7586976

Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis.

O Di Munno1, M Mazzantini, P Massei, M Ferdeghini, N Pitaro, A Latorraca, C Ferri.   

Abstract

Forty-three female patients with systemic sclerosis divided into subgroups based on the extent of skin involvement and the presence of calcinosis, and 50 sex and age-matched healthy controls were investigated for bone mineral density (BMD) on the basis of radial (dual photon absorptiometry, Osteograph, NIM), lumbar, and total body measurements (dual energy X-ray absorptiometry, Lunar DPX, Lunar Corp.), and for parameters of calcium metabolism. The patients showed a lower BMD (mean +/- SD; mg/cm2) than the controls at the radial (313 +/- 69 vs 347 +/- 73; p < 0.005), lumbar (974 +/- 143 vs 1081 +/- 154; p < 0.005), and total body (997 +/- 82 vs 1075 +/- 109; p < 0.05) determinations. The patients with the diffuse form of skin involvement had lower values than those with the limited form. There was a negative correlation between BMD and the duration of the disease. The presence of calcinosis was not found to have any effect on BMD. Calcium metabolism was found to be normal in each subgroup. It may be concluded that generalized osteoporosis is a feature of systemic sclerosis, with and without calcinosis. The extent and duration of the disease may play a role in determining bone loss.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7586976     DOI: 10.1007/BF02207673

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

2.  Age at menopause of females with systemic sclerosis.

Authors:  J Serup; H K Hagdrup
Journal:  Acta Derm Venereol       Date:  1983       Impact factor: 4.437

3.  Bone mineral content in systemic sclerosis measured by photonabsorptiometry.

Authors:  J Serup; H Hagdrup; E Tvedegaard
Journal:  Acta Derm Venereol       Date:  1983       Impact factor: 4.437

4.  Osteopenia in systemic sclerosis. Evidence of a participating role of earlier menopause.

Authors:  G La Montagna; M Vatti; G Valentini; G Tirri
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

5.  Influence of body habitus and race on bone mineral density of the midradius, hip, and spine in aging women.

Authors:  D P DeSimone; J Stevens; J Edwards; J Shary; L Gordon; N H Bell
Journal:  J Bone Miner Res       Date:  1989-12       Impact factor: 6.741

6.  Classification of systemic sclerosis (scleroderma): relationship of cutaneous subgroups in early disease to outcome and serologic reactivity.

Authors:  A T Masi
Journal:  J Rheumatol       Date:  1988-06       Impact factor: 4.666

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  The effects of race and body habitus on bone mineral density of the radius, hip, and spine in premenopausal women.

Authors:  Y Liel; J Edwards; J Shary; K M Spicer; L Gordon; N H Bell
Journal:  J Clin Endocrinol Metab       Date:  1988-06       Impact factor: 5.958

9.  Cutaneous and serologic subsets of systemic sclerosis.

Authors:  C Ferri; L Bernini; R Cecchetti; A Latorraca; G Marotta; G Pasero; R Neri; S Bombardieri
Journal:  J Rheumatol       Date:  1991-12       Impact factor: 4.666

10.  Scleroderma (progressive systemic sclerosis): progress and course based on a personal series of 118 cases.

Authors:  A J Barnett
Journal:  Med J Aust       Date:  1978-08-12       Impact factor: 7.738

View more
  13 in total

1.  Low bone mass in juvenile onset sclerosis systemic: the possible role for 25-hydroxyvitamin D insufficiency.

Authors:  Samuel Katsuyuki Shinjo; Eloisa Bonfá; Valéria de Falco Caparbo; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2010-03-25       Impact factor: 2.631

2.  Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status.

Authors:  Yousra Ibn Yacoub; Bouchra Amine; Assia Laatiris; Fahd Wafki; Fatima Znat; Najia Hajjaj-Hassouni
Journal:  Rheumatol Int       Date:  2011-09-27       Impact factor: 2.631

3.  Vertebral fracture prevalence and measurement of the scanographic bone attenuation coefficient on CT-scan in patients with systemic sclerosis.

Authors:  Marine Fauny; Elodie Bauer; Eliane Albuisson; Julia Perrier-Cornet; Joëlle Deibener; François Chabot; Damien Mandry; Olivier Huttin; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  Rheumatol Int       Date:  2018-08-21       Impact factor: 2.631

4.  Risk factors for body composition abnormalities in systemic sclerosis.

Authors:  Thais F Marighela; Patrícia de S Genaro; Marcelo M Pinheiro; Vera L Szejnfeld; Cristiane Kayser
Journal:  Clin Rheumatol       Date:  2013-04-03       Impact factor: 2.980

5.  Acroosteolysis and bone metabolism parameters distinguish female patients with limited systemic sclerosis with and without calcinosis: a case control study.

Authors:  Marilia M Sampaio-Barros; Lorena C M Castelo Branco; Liliam Takayama; Marco Antonio G Pontes Filho; Percival D Sampaio-Barros; Rosa Maria R Pereira
Journal:  Clin Rheumatol       Date:  2019-06-19       Impact factor: 2.980

6.  Relationship between ectopic calcifications and bone fragility depicted on computed tomography scan in 70 patients with systemic sclerosis.

Authors:  Marine Fauny; Elodie Bauer; Edem Allado; Eliane Albuisson; Joëlle Deibener; François Chabot; Damien Mandry; Olivier Huttin; Isabelle Chary-Valckenaere; Damien Loeuille
Journal:  J Scleroderma Relat Disord       Date:  2022-06-28

7.  Calcinosis is associated with digital ulcers and osteoporosis in patients with systemic sclerosis: A Scleroderma Clinical Trials Consortium study.

Authors:  Antonia Valenzuela; Murray Baron; Ariane L Herrick; Susanna Proudman; Wendy Stevens; Tatiana S Rodriguez-Reyna; Alessandra Vacca; Thomas A Medsger; Monique Hinchcliff; Vivien Hsu; Joy Y Wu; David Fiorentino; Lorinda Chung
Journal:  Semin Arthritis Rheum       Date:  2016-06-02       Impact factor: 5.532

8.  Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis.

Authors:  Addolorata Corrado; Ripalta Colia; Angiola Mele; Valeria Di Bello; Antonello Trotta; Anna Neve; Francesco Paolo Cantatore
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

9.  Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a case-control study.

Authors:  Mathilde Marot; Antoine Valéry; Eric Esteve; Guido Bens; Adelheid Müller; Stéphanie Rist; Hechmi Toumi; Eric Lespessailles
Journal:  Oncotarget       Date:  2015-06-20

10.  Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: a case control study.

Authors:  Marco Atteritano; Stefania Sorbara; Gianluca Bagnato; Giovanni Miceli; Donatella Sangari; Salvatore Morgante; Elisa Visalli; Gianfilippo Bagnato
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.